Abstract: This review provides a focused analysis of recent developments in the design, synthesis, and pharmacological evaluation of benzoxazole derivatives, emphasizing their emerging role as versatile therapeutic scaffolds. By systematically examining studies published across major scientific databases, the article highlights how structural modifications to the benzoxazole core translate into distinct bioactivities, particularly in antimicrobial, anticancer, antitubercular, anti-inflammatory, analgesic, and anthelmintic domains. Special emphasis is placed on Structure–Activity Relationship (SAR) trends, in which variations such as heteroatom substitutions, aryl linkages, and bulky substituents significantly influenced biological potency. Comparative cell line testing results are consolidated to illustrate how specific substitutions modulate cytotoxic responses across various cancer models. The novelty of this review lies in its integrated discussion of SAR findings alongside therapeutic applications, offering insights into how subtle functionalization patterns enhance pharmacological potential. Additionally, the review underscores critical gaps that remain in in-vivo validation and translational studies. Overall, it not only consolidates recent findings but also provides perspectives for future medicinal chemistry strategies aimed at advancing benzoxazole-based agents toward clinical utility.
Vashisht et al. (Thu,) studied this question.